Literature DB >> 8979107

Molecular basis for protein C hereditary deficiency.

M Aiach1, S Gandrille.   

Abstract

The clinical presentation of hereditary protein C deficiency is highly variable. Homozygosity and compound heterozygosity have been linked to severe thrombotic complications early in the life. Heterozygous patients have a moderate form of the disease with deep venous thrombosis during adulthood. In the French population, we found 53 different mutations in 90 families. The amount of the protein C produced by the mutant allele as well as the genetic status partly account for the variable clinical expression. Other gene may also be involved: Arg 506 to Gln factor V mutation shows a frequency of 10 to 20% in symptomatic protein C deficient patients. Some protein C gene mutations are associated with a non functional circulating protein; most of them are located in the GLA domain and in the serine protease domain. The biochemical characterization of a few of theses variants has shown the important role of some amino acids on the activation and the mechanism of action of protein C.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8979107     DOI: 10.1159/000217280

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  1 in total

1.  Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.

Authors:  I B Johnstone; C A Martin
Journal:  Can J Vet Res       Date:  2000-04       Impact factor: 1.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.